Suppr超能文献

PET 血管活性评分预测 Takayasu 动脉炎患者新的血管造影病变:一项中国队列研究。

PET vascular activity score for predicting new angiographic lesions in patients with Takayasu arteritis: a Chinese cohort study.

机构信息

Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.

Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.

出版信息

Rheumatology (Oxford). 2023 Oct 3;62(10):3310-3316. doi: 10.1093/rheumatology/kead056.

Abstract

OBJECTIVE

To investigate the ability of 18F-fluorodeoxyglucose PET/CT to predict new lesions in Takayasu arteritis.

METHODS

Eighty-two Chinese patients with newly diagnosed Takayasu arteritis were recruited. Their clinical characteristics, serum biomarkers and imaging results were recorded at baseline and every visit. They were followed up for at least 2 years. New angiographic lesions were evaluated by magnetic resonance angiography. Baseline PET vascular activity scores (PETVAS) for predicting new lesions were evaluated.

RESULTS

At baseline, a moderate correlation was observed between PETVAS and ESR (r = 0.74, P < 0.01) and CRP level (r = 0.69, P < 0.01). Overall, 18 (22%) patients showed new lesions on imaging during a median follow-up time of 36 months. The median time to the first occurrence of new lesions was 18 months. Compared with patients without new lesions, the patients with new lesions included more female patients (67.2% vs 94.4%, P = 0.03), patients with higher ESR values (20 vs 49, P = 0.02) and patients with active disease (62.5% vs 94.4%, P < 0.01). Multivariate Cox regression analysis revealed PETVAS was an independent risk factor for new angiographic lesions (PETVAS ≥8, hazard ratio = 7.56; 95% CI 2.20, 26.01, P < 0.01) with adjustment of age, sex, chest pain, ESR and Physician Global Assessment. Furthermore, patients with PETVAS ≥8 at baseline were more likely to experience adverse events including arterial ischaemic events during the follow-up.

CONCLUSION

PETVAS showed good performance in predicting new lesions in Takayasu arteritis.

摘要

目的

研究 18F-氟代脱氧葡萄糖 PET/CT 预测大动脉炎新病变的能力。

方法

共纳入 82 例新诊断为大动脉炎的中国患者。在基线和每次就诊时记录其临床特征、血清生物标志物和影像学结果。他们的随访时间至少为 2 年。通过磁共振血管造影评估新的血管造影病变。评估基线 PET 血管活性评分(PETVAS)预测新病变的能力。

结果

基线时,PETVAS 与 ESR(r=0.74,P<0.01)和 CRP 水平(r=0.69,P<0.01)呈中度相关。总体而言,在中位随访 36 个月期间,18(22%)例患者影像学上出现新病变。首次发生新病变的中位时间为 18 个月。与无新病变的患者相比,有新病变的患者中女性更多(67.2%比 94.4%,P=0.03),ESR 值更高(20 比 49,P=0.02),且疾病处于活动期的患者更多(62.5%比 94.4%,P<0.01)。多变量 Cox 回归分析显示,PETVAS 是新血管造影病变的独立危险因素(PETVAS≥8,危险比=7.56;95%CI 2.20,26.01,P<0.01),校正年龄、性别、胸痛、ESR 和医师整体评估后。此外,基线 PETVAS≥8 的患者在随访期间更有可能发生包括动脉缺血性事件在内的不良事件。

结论

PETVAS 在预测大动脉炎新病变方面具有良好的性能。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验